NASDAQ · Medical - Devices

Bioventus Inc. (BVS) Stock

$13.07 +2.96% NASDAQ: BVS Healthcare

Valuation

MetricValue
Price$13.07
Market Cap$885.13M
P/E Ratio16.85
P/B Ratio4.02
P/S Ratio1.58
EPS (TTM)$0.34
52-Week High$15.89
52-Week Low$6.37
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE28.39%
ROA8.09%
ROCE11.87%
Gross Margin67.78%
Operating Margin10.64%
Net Margin9.36%
Debt/Equity1.16
Current Ratio1.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$431.0M$512.0M$512.0M$573.0M$568.0M
Operating Profit$12.0M$-167.0M$-82.0M$-12.0M$59.0M
Net Profit$19.0M$-159.0M$-156.0M$-34.0M$23.0M
EPS$0.43$-2.59$-2.49$-0.52$0.33
Op Margin2.8%-32.7%-15.9%-2.1%10.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.2B$1.4B$811.0M$728.0M$684.0M
Total Liabilities$692.0M$960.0M$590.0M$542.0M$455.0M
Cash$44.0M$30.0M$37.0M$42.0M$51.0M
Borrowings$358.0M$418.0M$395.0M$336.0M$311.0M

Latest News

Bioventus (BVS) Stock Looks Overvalued On Earnings Yet Backed By Broader Checks Simply Wall St. · Jul 10, 2026 Are Medical Stocks Lagging Caribou Biosciences (CRBU) This Year? Zacks · Jul 9, 2026 Are You Looking for a Top Momentum Pick? Why Bioventus (BVS) is a Great Choice Zacks · Jul 8, 2026 Wall Street Analysts Predict a 28.81% Upside in Bioventus (BVS): Here's What You Should Know Zacks · Jul 8, 2026 Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock? Zacks · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$23.0M$-14.0M$15.0M$39.0M$74.0M
Investing Cash Flow$-305.0M$-118.0M$8.0M$22.0M$-6.0M
Financing Cash Flow$-2.0M$-3.0M$-4.0M$3.0M$-21.0M
Net Cash Flow$12.0M$-67.0M$5.0M$5.0M$10.0M
Free Cash Flow$2.0M$-15.0M$8.0M$38.0M$71.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA12.40
FCF Yield10.28%
Quick Ratio1.17
Interest Coverage3.11
Return 1Y77.43%
Return 3Y222.47%
Return 5Y-28.42%

Ownership

Insiders Held11.75%
Institutions Held78.33%
Institutions Float Held88.76%
Institutional HolderSharesReport Date
Essex Woodlands Management Inc.13,021,3242026-03-31
Juniper Investment Company, LLC6,939,3572026-03-31
Nantahala Capital Management, LLC6,122,4032026-03-31
Blackrock Inc.3,133,5412026-03-31
Vanguard Capital Management LLC1,714,7072026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANIKAnika Therapeutics Inc. $19.58 +1.82% -70.87 $262.04M 0.00%
BBLGBone Biologics Corp $0.47 -0.43% -0.26 $845628 0.00%
IARTIntegra LifeSciences Holdings Corporation $13.44 +0.22% -176.57 $1.05B 0.00%
MDXGMiMedx Group, Inc $4.67 +1.08% 115.74 $680.70M 0.00%
OFIXOrthofix Medical Inc. $9.17 +1.89% -5.92 $370.67M 0.00%

About Bioventus Inc.

Bioventus Inc. is led by CEO Robert E. Claypoole, employs 930 people, headquartered in US, publicly traded since 2021.

Bioventus Inc. (BVS) stock trades at $13.07 with a market capitalization of $885.13M. The stock is valued at a price-to-earnings (P/E) ratio of 16.85, price-to-book of 4.02, price-to-sales of 1.58. Over the past 52 weeks the stock has ranged between $6.37 and $15.89, and currently trades 17.8% below its 52-week high.

On profitability, Bioventus Inc. generates a return on equity (ROE) of 28.39% — well above the market average, a sign of a high-quality business, return on capital employed of 11.87%, an operating margin of 10.64%, a net profit margin of 9.36%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides